Editorial: Molecular and cellular pathways leading to mitochondrial dysfunction and neurodegeneration: lessons from in vivo models, volume II.

Publication date: Jan 07, 2025

Type	Source	Name
disease	MESH	mitochondrial dysfunction
pathway	REACTOME	Reproduction
disease	MESH	Parkinson’s disease
drug	DRUGBANK	Metformin
disease	MESH	SARS CoV 2 infection
drug	DRUGBANK	Cholesterol
disease	MESH	optic atrophy
disease	MESH	muscular atrophy
disease	MESH	peripheral neuropathy
disease	MESH	cataracts
disease	MESH	myopathy
disease	MESH	premature death
pathway	REACTOME	Mitophagy
disease	MESH	defects
disease	IDO	process
pathway	REACTOME	Translation
pathway	REACTOME	Mitochondrial translation
disease	MESH	neurodegenerative disorder
drug	DRUGBANK	Coenzyme M
disease	IDO	intervention
pathway	KEGG	Circadian rhythm
drug	DRUGBANK	Methionine
drug	DRUGBANK	Dopamine
drug	DRUGBANK	Guanosine
disease	MESH	oxidative stress
drug	DRUGBANK	ATP
disease	IDO	production
disease	MESH	neurological disorders
disease	MESH	neurological manifestations
disease	MESH	memory deficits
disease	MESH	cognitive impairments
disease	MESH	neurodevelopmental disorders
disease	MESH	viral infections

(Visited 1 times, 1 visits today)